Regencell Bioscience Holdings Stock Performance
| RGC Stock | USD 60.00 44.34 283.14% |
Regencell Bioscience holds a performance score of 18 on a scale of zero to a hundred. The company holds a Beta of 0.66, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Regencell Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Regencell Bioscience is expected to be smaller as well. Use Regencell Bioscience jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Regencell Bioscience.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 283.14 | Five Day Return 274.53 | Year To Date Return 47.2 K | Ten Year Return 21.6 K | All Time Return 21.6 K |
1 | Need To Know Analysts Just Made A Substantial Cut To Their Regal Partners Limited Estimates | 04/10/2025 |
2 | Regal Partners Faces Market Scrutiny Following Biotech Exposure | 04/24/2025 |
3 | Regencell Bioscience Trading Activity Resumes RGC Stock News | 05/13/2025 |
4 | Bull of the Day TaskUs | 05/20/2025 |
5 | Regal Court Reporting Recognized by Orange County Business Journals Family Owned Business Awards | 05/28/2025 |
6 | Kalkine Regal Rexnord Corporation Earnings Per Share | 05/29/2025 |
7 | Regencell Bioscience The Most Overvalued Stock In Biotech - Seeking Alpha | 06/03/2025 |
8 | Regencell stock climbs in a narrative-led rally - Seeking Alpha | 06/06/2025 |
9 | Charming, Regal, and Award-Winning The Kings Throne Inn and Guest House Receives 2025 Consumer Choice Award for Bed and Breakfast in Toledo | 06/09/2025 |
10 | Inspirato Partners with Regal Wings to Elevate the Way Members Fly ISPO Stock News | 06/11/2025 |
11 | Kobrand Fine Wine Spirits Selects Regal Wine Company As California Distributor | 06/12/2025 |
12 | Whats Going On With Regencell Bioscience Stock Today | 06/16/2025 |
| Begin Period Cash Flow | 1.6 M |
Regencell | Build AI portfolio with Regencell Stock |
Regencell Bioscience Relative Risk vs. Return Landscape
If you would invest 3,077 in Regencell Bioscience Holdings on March 19, 2025 and sell it today you would earn a total of 2,923 from holding Regencell Bioscience Holdings or generate 95.0% return on investment over 90 days. Regencell Bioscience Holdings is generating 10.3184% of daily returns assuming volatility of 44.4983% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Regencell, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Regencell Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regencell Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Regencell Bioscience Holdings, and traders can use it to determine the average amount a Regencell Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2319
| Best Portfolio | Best Equity | RGC | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 44.5 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.96 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Regencell Bioscience is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regencell Bioscience by adding it to a well-diversified portfolio.
Regencell Bioscience Fundamentals Growth
Regencell Stock prices reflect investors' perceptions of the future prospects and financial health of Regencell Bioscience, and Regencell Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Regencell Stock performance.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 29.66 B | ||||
| Shares Outstanding | 13.01 M | ||||
| Price To Earning | 26.21 X | ||||
| Price To Book | 3,610 X | ||||
| EBITDA | (3.62 M) | ||||
| Net Income | (4.36 M) | ||||
| Cash And Equivalents | 59.41 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 85.74 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 13.94 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (4 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 7.74 B | ||||
| Total Asset | 8.44 M | ||||
| Retained Earnings | (21.62 M) | ||||
| Working Capital | 7.92 M | ||||
| Current Asset | 438.2 M | ||||
| Current Liabilities | 551.3 M | ||||
About Regencell Bioscience Performance
By analyzing Regencell Bioscience's fundamental ratios, stakeholders can gain valuable insights into Regencell Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Regencell Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Regencell Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 78.15 | 82.06 | |
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.12 | 0.08 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | (0.13) | (0.14) |
Things to note about Regencell Bioscience performance evaluation
Checking the ongoing alerts about Regencell Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Regencell Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Regencell Bioscience is way too risky over 90 days horizon | |
| Regencell Bioscience appears to be risky and price may revert if volatility continues | |
| Reported Net Loss for the year was (4.36 M) with profit before taxes, overhead, and interest of 0. | |
| Regencell Bioscience Holdings has about 59.41 K in cash with (4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Regencell Bioscience has a poor financial position based on the latest SEC disclosures | |
| Roughly 94.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from benzinga.com: Whats Going On With Regencell Bioscience Stock Today |
- Analyzing Regencell Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Regencell Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Regencell Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Regencell Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Regencell Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Regencell Bioscience's stock. These opinions can provide insight into Regencell Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |